VDAC1 and cancer: VDAC’s unique physiological role as a mitochondrial regulator (Lemasters and Holmuhamedov, 2006) makes it a strong candidate for pharmaceutical intervention in diseases such as cancer, cardiovascular disorders, diabetes, and neurodegeneration where mitochondrial dysfunction is known.